Search

everythinglearnresearchcommunity

for

Search:↓

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Wharton's Jelly stem cell medium may help treat skin issues in Systemic Sclerosis.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

The protein STAT3 slows down cell growth by blocking the FST gene, which affects hair development in sheep.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Chitosan-encapsulated Cordyceps militaris reduces lung cell damage from pollution.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

Skin bacteria help heal wounds and restore healthy skin.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

Biomimetic synthetic vesicles could improve precision medicine by combining natural and synthetic benefits.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.

Caloric stress and differentiation increase IRES translation, affecting stem cell function and potential therapies.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Atopic dermatitis increases the risk of some autoimmune diseases.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Tight junctions help control skin shedding and may be targets for treating certain skin conditions.

Genetics, hormones, and microbiome changes contribute to hidradenitis suppurativa.

New treatments for seborrheic dermatitis show promise for difficult cases.

A holistic approach combining lifestyle changes, stress management, exercise, and herbal medicine can effectively treat and prevent keloids.